Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
epinephrine	O
/	O
sulfite	O
Attending:	O
___.	O
Chief	O
Complaint:	O
nausea	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
GJ	O
tube	O
placement	O
Dilation	O
of	O
sphincter	O
EGD	O
History	O
of	O
Present	O
Illness:	O
___	O
w/prior	O
breast	O
cancer,	O
abdominal	O
radiation,	O
resulting	O
in	O
chronic	O
diarrhea,	O
presenting	O
with	O
nausea	O
and	O
vomiting.	O
Patient	O
reports	O
2	O
days	O
of	O
inability	O
to	O
tolerate	O
po	O
or	O
home	O
meds	O
due	O
to	O
nausea	O
and	O
vomiting.	O
She	O
feels	O
that	O
something	O
is	O
stuck	O
in	O
her	O
esophagus.	O
She	O
denies	O
any	O
abdominal	O
pain,	O
fevers,	O
or	O
chills.	O
She	O
has	O
chronic	O
diarrhea	O
maybe	O
worse	O
than	O
usual	O
for	O
the	O
past	O
month.	O
No	O
chest	O
pain	O
or	O
shortness	O
of	O
breath.	O
In	O
ED	O
CT	O
with	O
enteritis.	O
Pt	O
given	O
cipro/flagyl,	O
zofran	O
and	O
2Lns.	O
ROS:	O
+as	O
above,	O
otherwise	O
reviewed	O
and	O
negative	O
Past	O
Medical	O
History:	O
Positive	O
for	O
hypertension	O
and	O
reflux.	O
She	O
also	O
has	O
a	O
prior	O
history	O
of	O
a	O
uterine	O
cancer	O
and	O
underwent	O
a	O
TAH-BSO	O
followed	O
by	O
radiation	O
therapy	O
in	O
___.	O
She	O
has	O
at	O
times	O
diarrhea.	O
She	O
also	O
has	O
a	O
history	O
of	O
a	O
stress	B-Vertebral_compression_fracture
fracture.	B-Vertebral_compression_fracture
Past	O
oncologic	O
history	O
Pt	O
presented	O
to	O
PCP	O
with	O
palpable	O
left	O
breast	O
mass.	O
-	O
___	O
diag	O
breast	O
imaging:	O
large	O
conglomerate	O
solid	O
mass	O
in	O
left	O
breast	O
involving	O
almost	O
the	O
entire	O
breast	O
with	O
abnormal	O
left	O
axillary	O
LNs.	O
-	O
___	O
CNB:	O
1.1	O
cm	O
grade	O
3	O
IDLC,	O
ER	O
pos,	O
PR	O
neg,	O
HER2	O
neg.	O
LN	O
FNA	O
positive	O
for	O
malignant	O
cells.	O
-	O
___	O
staging	O
evaluation	O
as	O
below,	O
notable	O
for	O
borderline	O
lymphadenopathy	O
of	O
left	O
supraclavicular	O
region,	O
internal	O
mammary	O
chain	O
and	O
left	O
axillary	O
regions.	O
-	O
___	O
left	O
mastectomy/ALND:	O
Multiple	O
foci,	O
largest	O
9.5	O
cm	O
grade	O
3	O
invasive	O
carcinoma	O
with	O
predominantly	O
pleomorphic	O
lobular	O
features,	O
satellite	O
skin	O
foci	O
(T4b),	O
negative	O
deep	O
margin,	O
+ALND	O
___,	O
stage	O
IIIB.	O
-	O
___	O
start	O
fulvestrant	O
-	O
___	O
complete	O
adjuvant	O
RT	O
-	O
___	O
switch	O
to	O
anastrozole	O
Social	O
History:	O
___	O
Family	O
History:	O
Negative	O
for	O
breast,	O
ovarian,	O
and	O
any	O
other	O
kind	O
of	O
cancer.	O
Her	O
mother	O
died	O
at	O
the	O
age	O
of	O
___	O
of	O
a	O
myocardial	O
infarction.	O
Her	O
father	O
died	O
at	O
___	O
of	O
heart	O
disease	O
and	O
had	O
a	O
pacemaker.	O
She	O
has	O
one	O
sister,	O
___,	O
and	O
one	O
brother,	O
___,	O
who	O
are	O
still	O
alive.	O
Physical	O
Exam:	O
Vitals:	O
T:97.9	O
BP:90/41	O
P:65	O
R:18	O
O2:96%ra	O
PAIN:	O
0	O
General:	O
nad	O
EYES:	O
anicteric	O
Lungs:	O
clear	O
CV:	O
rrr	O
no	O
m/r/g	O
Abdomen:	O
bowel	O
sounds	O
present,	O
soft,	O
nt/nd	O
Ext:	O
no	O
e/c/c	O
Skin:	O
no	O
rash	O
Neuro:	O
alert,	O
follows	O
commands	O
Discharge	O
Exam:	O
110/80	O
AF	O
70	O
Gen:	O
Cachectic	B-Malnutrition
female,	O
pleasant	O
Lung:	O
CTA	O
B	O
CV:	O
RRR,	O
no	O
m/r/g	O
Abd:	O
+	O
G	O
tube	O
Ext:	O
LUE	O
slightly	O
larger	O
than	O
right	O
UE	O
Pertinent	O
Results:	O
___	O
08:50PM	O
GLUCOSE-96	O
UREA	O
N-21*	O
CREAT-0.7	O
SODIUM-145	O
POTASSIUM-3.9	O
CHLORIDE-106	O
TOTAL	O
CO2-26	O
ANION	O
GAP-17	O
___	O
08:50PM	O
ALT(SGPT)-14	O
AST(SGOT)-38	O
ALK	O
PHOS-85	O
TOT	O
BILI-0.4	O
___	O
08:50PM	O
LIPASE-23	O
___	O
08:50PM	O
cTropnT-<0.01	O
___	O
08:50PM	O
ALBUMIN-4.0	O
CALCIUM-8.9	O
PHOSPHATE-2.4*	O
MAGNESIUM-1.9	O
___	O
08:50PM	O
WBC-8.2#	O
RBC-3.44*	O
HGB-10.9*	O
HCT-32.8*	O
MCV-95	O
MCH-31.6	O
MCHC-33.1	O
RDW-15.2	O
___	O
08:50PM	O
NEUTS-89.3*	O
LYMPHS-5.1*	O
MONOS-5.2	O
EOS-0.2	O
BASOS-0.1	O
___	O
08:50PM	O
PLT	O
COUNT-284	O
___	O
12:20AM	O
URINE	O
COLOR-Yellow	O
APPEAR-Clear	O
SP	O
___	O
___	O
12:20AM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-30	O
GLUCOSE-NEG	O
KETONE-10	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-6.0	O
LEUK-NEG	O
Discharge	O
Labs:	O
___	O
08:25AM	O
BLOOD	O
WBC-4.0#	O
RBC-3.19*	O
Hgb-9.2*	O
Hct-29.4*	O
MCV-92	O
MCH-29.0	O
MCHC-31.4	O
RDW-15.9*	O
Plt	O
___	O
___	O
07:20AM	O
BLOOD	O
Glucose-102*	O
UreaN-10	O
Creat-0.4	O
Na-137	O
K-4.0	O
Cl-102	O
HCO3-29	O
AnGap-10	O
___	O
07:20AM	O
BLOOD	O
Calcium-8.4	O
Phos-2.9	O
Mg-1.7	O
U/S	O
-	O
left	O
upper	O
extremity	O
1.	O
No	O
evidence	O
of	O
deep	O
vein	O
thrombosis	O
in	O
the	O
left	O
upper	O
extremity.	O
2.	O
Clot	O
is	O
noted	O
in	O
the	O
cephalic	O
vein	O
at	O
the	O
level	O
of	O
the	O
proximal	O
forearm.	O
This	O
is	O
a	O
superficial	O
vein	O
and	O
does	O
not	O
represent	O
a	O
DVT.	O
3.	O
Superficial,	O
diffuse	O
soft	O
tissue	O
edema	O
is	O
noted	O
in	O
the	O
region	O
of	O
the	O
antecubital	O
fossa.	O
INDICATION:	O
___	O
year	O
old	O
woman	O
with	O
esophageal	O
stricture	O
and	O
malnutrition.	B-Malnutrition
COMPARISON:	O
Esophagogram	O
___,	O
CT	O
abdomen	O
and	O
pelvis	O
___.	O
TECHNIQUE:	O
OPERATORS:	O
Dr.	O
___	O
radiology	O
fellow)	O
and	O
Dr.	O
___	O
radiology	O
attending)	O
performed	O
the	O
procedure.	O
The	O
attending,	O
Dr.	O
___	O
supervised	O
the	O
trainee	O
during	O
the	O
key	O
components	O
of	O
the	O
procedure	O
and	O
has	O
reviewed	O
and	O
agrees	O
with	O
the	O
trainee's	O
findings	O
ANESTHESIA:	O
Moderate	O
sedation	O
was	O
provided	O
by	O
administrating	O
divided	O
doses	O
of	O
50mcg	O
of	O
fentanyl	O
and	O
0.25	O
mg	O
of	O
midazolam	O
throughout	O
the	O
total	O
intra-service	O
time	O
of	O
40	O
during	O
which	O
the	O
patient's	O
hemodynamic	O
parameters	O
were	O
continuously	O
monitored	O
by	O
an	O
independent	O
trained	O
radiology	O
nurse.	O
1%	O
lidocaine	O
was	O
injected	O
in	O
the	O
skin	O
and	O
subcutaneous	O
tissues	O
overlying	O
the	O
access	O
site.	O
MEDICATIONS:	O
Fentanyl	O
and	O
midazolam.	O
CONTRAST:	O
20	O
ml	O
of	O
Optiray	O
contrast.	O
FLUOROSCOPY	O
TIME	O
AND	O
DOSE:	O
13	O
min,	O
412	O
cGycm2	O
PROCEDURE:	O
1.	O
Placement	O
of	O
a	O
___	O
___	O
gastrojejunostomy	O
tube.	O
PROCEDURE	O
DETAILS:	O
Following	O
the	O
discussion	O
of	O
the	O
risks,	O
benefits	O
and	O
alternatives	O
to	O
the	O
procedure,	O
written	O
informed	O
consent	O
was	O
obtained	O
from	O
the	O
patient.	O
The	O
patient	O
was	O
then	O
brought	O
to	O
the	O
angiography	O
suite	O
and	O
placed	O
semi	O
upright	O
on	O
the	O
exam	O
table.	O
A	O
pre-procedure	O
time-out	O
was	O
performed	O
per	O
___	O
protocol.	O
Lidocaine	O
jelly	O
and	O
spray	O
was	O
applied	O
to	O
the	O
left	O
nostril	O
and	O
back	O
of	O
the	O
throat.	O
An	O
angled	O
glide	O
catheter	O
was	O
advanced	O
through	O
the	O
left	O
nostril	O
into	O
the	O
stomach	O
under	O
fluoroscopy	O
and	O
glidewire	O
guidance.	O
The	O
tube	O
site	O
was	O
prepped	O
and	O
draped	O
in	O
the	O
usual	O
sterile	O
fashion.	O
A	O
scout	O
image	O
of	O
the	O
abdomen	O
was	O
obtained.	O
The	O
stomach	O
was	O
insufflated	O
through	O
the	O
indwelling	O
nasogastric	O
catheter.	O
Using	O
a	O
marker,	O
the	O
skin	O
was	O
marked	O
using	O
palpation	O
to	O
feel	O
the	O
costal	O
margins	O
and	O
the	O
liver	O
edge	O
was	O
marked	O
using	O
ultrasound.	O
Ultrasound	O
images	O
were	O
not	O
stored.	O
Under	O
fluoroscopic	O
guidance,	O
3	O
T	O
fastener	O
buttons	O
were	O
sequentially	O
deployed	O
in	O
a	O
triangular	O
position	O
elevating	O
the	O
stomach	O
to	O
the	O
anterior	O
abdominal	O
wall.	O
Intra-gastric	O
position	O
was	O
confirmed	O
with	O
aspiration	O
of	O
air	O
and	O
injection	O
of	O
contrast.	O
A	O
19	O
gauge	O
needle	O
was	O
introduced	O
under	O
fluoroscopic	O
guidance	O
and	O
position	O
confirmed	O
using	O
an	O
injection	O
of	O
dilute	O
contrast.	O
The	O
needle	O
trajectory	O
was	O
directed	O
towards	O
the	O
pylorus.	O
A	O
___	O
wire	O
was	O
introduced	O
and	O
coiled	O
within	O
the	O
stomach.	O
A	O
small	O
skin	O
incision	O
was	O
made	O
along	O
the	O
needle	O
and	O
the	O
needle	O
was	O
removed.	O
A	O
7	O
___	O
sheath	O
was	O
placed.	O
A	O
Kumpe	O
catheter	O
was	O
then	O
introduced	O
over	O
the	O
wire	O
and	O
the	O
___	O
was	O
exchanged	O
for	O
a	O
Glidewire.	O
The	O
Glidewire	O
and	O
a	O
Kumpe	O
cathter	O
was	O
used	O
to	O
advance	O
the	O
wire	O
into	O
the	O
___	O
part	O
of	O
the	O
duodenum.	O
The	O
Glidewire	O
was	O
then	O
exchanged	O
for	O
stiff	O
glidewire.	O
The	O
sheath	O
was	O
then	O
removed	O
and	O
serial	O
dilations	O
were	O
performed.	O
A	O
peel-away	O
sheath	O
was	O
placed	O
over	O
the	O
wire.	O
A	O
14	O
___	O
___	O
gastrojejunostomy	O
catheter	O
was	O
advanced	O
over	O
the	O
wire	O
into	O
position.	O
The	O
sheath	O
was	O
then	O
peeled	O
away.	O
The	O
wire	O
and	O
sheath	O
were	O
removed.	O
The	O
catheter	O
was	O
locked	O
by	O
forming	O
the	O
retaining	O
loop	O
in	O
the	O
stomach	O
after	O
confirming	O
the	O
position	O
of	O
the	O
catheter	O
with	O
a	O
contrast	O
injection.	O
The	O
catheter	O
was	O
then	O
flushed,	O
capped	O
and	O
secured	O
to	O
the	O
skin	O
with	O
flexi	O
track.	O
Sterile	O
dressings	O
were	O
applied.	O
The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
there	O
were	O
no	O
immediate	O
complications.	O
FINDINGS:	O
1.	O
Successful	O
placement	O
of	O
a	O
14	O
___	O
___	O
gastrojejunostomy	O
tube	O
with	O
its	O
tip	O
in	O
the	O
proximal	O
jejunum.	O
CT	O
Abd	O
&	O
Pelvis	O
With	O
Contrast	O
(___)	O
1.	O
No	O
signs	O
of	O
small	O
bowel	O
obstruction.	O
Fluid	O
filled	O
loops	O
of	O
jejunum	O
and	O
ileum	O
with	O
areas	O
of	O
wall	O
thickening	O
likely	O
represent	O
enteritis.	O
2.	O
Extensive	O
atherosclerotic	O
disease	O
with	O
chronic	O
occlusion	O
of	O
the	O
left	O
common	O
iliac	O
artery	O
with	O
extension	O
into	O
the	O
internal	O
and	O
external	O
iliac	O
arteries.	O
3.	O
Multiple	O
thoracolumbar	O
spinal	O
compression	O
deformities,	O
similar	O
to	O
___.	O
KUB	O
___	O
COMPARISON:	O
Abdominal	O
radiographs	O
from	O
___	O
and	O
___.	O
FINDINGS:	O
Frontal	O
supine	O
and	O
erect	O
abdominal	O
radiographs	O
demonstrate	O
a	O
the	O
gastrojejunal	O
to	O
the	O
projecting	O
over	O
the	O
left	O
upper	O
abdomen.	O
There	O
is	O
a	O
nonobstructive	O
bowel	O
gas	O
pattern.	O
Multiple	O
punctate	O
hyperdensities	O
projecting	O
over	O
the	O
lower	O
abdomen	O
likely	O
represent	O
flocculation	O
after	O
recent	O
enteric	O
injection	O
of	O
contrast.	O
IMPRESSION:	O
Nonobstructive	O
bowel	O
gas	O
pattern.	O
EGD	O
Third	O
attempt	O
A	O
previously	O
noted	O
5mm	O
benign	O
stricture	O
at	O
28cm	O
from	O
the	O
incisors	O
was	O
again	O
visualized.	O
The	O
standard	O
gastroscope	O
was	O
not	O
able	O
to	O
be	O
traverse	O
the	O
stricture.	O
A	O
8mm	O
balloon	O
was	O
introduced	O
for	O
dilation	O
and	O
the	O
diameter	O
was	O
progressively	O
increased	O
to	O
9	O
mm	O
successfully.	O
Stomach:	O
Not	O
examined.	O
Duodenum:	O
Not	O
examined.	O
Impression:	O
A	O
previously	O
noted	O
5mm	O
benign	O
stricture	O
at	O
28cm	O
from	O
the	O
incisors	O
was	O
again	O
visualized.	O
The	O
standard	O
gastroscope	O
was	O
not	O
able	O
to	O
be	O
traverse	O
the	O
stricture.	O
A	O
8mm	O
balloon	O
was	O
introduced	O
for	O
dilation	O
and	O
the	O
diameter	O
was	O
progressively	O
increased	O
to	O
9	O
mm	O
successfully	O
Otherwise	O
normal	O
EGD	O
to	O
lower	O
third	O
of	O
the	O
esophagus	O
Recommendations:	O
Repeat	O
EGD	O
for	O
dilation	O
in	O
2	O
weeks	O
with	O
Dr.	O
___.	O
Will	O
likely	O
need	O
___	O
dilation	O
under	O
flurosocopic	O
guidance.	O
If	O
any	O
chest	O
or	O
abdominal	O
pain,	O
fevers,	O
bleeding,	B-Upper_gastrointestinal_haemorrhage
difficulty	O
swallowing,	O
nausea,	O
vomiting	O
or	O
any	O
other	O
concerning	O
post	O
procedure	O
symptom,	O
please	O
call	O
the	O
advanced	O
endoscopy	O
fellow	O
on	O
call	O
___	O
___.	O
EGD	O
x2	O
Impression:	O
A	O
tight	O
pinhole	O
stricture	O
that	O
appeared	O
at	O
28	O
cm	O
from	O
the	O
incisors	O
was	O
identified.	O
The	O
esophageal	O
mucosa	O
to	O
the	O
level	O
of	O
the	O
stricture	O
was	O
normal.	O
At	O
the	O
stricture	O
there	O
was	O
edema,	O
exudate	O
and	O
ulceration	O
seen	O
likely	O
related	O
to	O
earlier	O
dilation.	O
A	O
guidewire	O
was	O
passed	O
under	O
fluorosocopic	O
guidance	O
into	O
a	O
dilated	O
stomach.	O
However,	O
its	O
short	O
angulated	O
path	O
beyond	O
the	O
stricture	O
suggested	O
a	O
foreshortened	O
esophagus.	O
With	O
the	O
aid	O
of	O
a	O
biliary	O
balloon,	O
contrast	O
was	O
injected	O
to	O
better	O
identify	O
the	O
anatomy	O
of	O
the	O
stricture	O
but	O
pooled	O
above	O
the	O
stricture.	O
Given,	O
an	O
unusual	O
anatomy	O
that	O
could	O
not	O
be	O
fully	O
defined	O
and	O
the	O
inflammation	O
due	O
to	O
ealier	O
dilation,	O
the	O
decision	O
was	O
made	O
to	O
posptpone	O
dilation	O
until	O
after	O
a	O
barium	O
swallow	O
could	O
be	O
obtained	O
to	O
delineate	O
the	O
stricture.	O
Recommendations:	O
Obtain	O
Barium	O
Swallow.	O
___	O
guided	O
PEG	O
placement	O
on	O
___	O
and	O
attempt	O
at	O
further	O
dilation	O
on	O
___.	O
If	O
any	O
fever,	O
worsening	O
abdominal	O
pain,	O
or	O
post	O
procedure	O
symptoms,	O
please	O
call	O
the	O
advanced	O
endoscopy	O
fellow	O
on	O
call	O
___/	O
pager	O
___.	O
Additional	O
notes:	O
The	O
procedure	O
was	O
performed	O
by	O
Dr.	O
___	O
the	O
GI	O
fellow.	O
The	O
attending	O
was	O
present	O
for	O
the	O
entire	O
procedure.	O
FINAL	O
DIAGNOSES	O
are	O
listed	O
in	O
the	O
impression	O
section	O
above.	O
Estimated	O
blood	O
loss	O
=	O
zero.	O
No	O
specimens	O
were	O
taken	O
for	O
pathology	O
EGDx1	O
Findings:	O
Esophagus:	O
Lumen:	O
A	O
benign	O
intrinsic	O
5	O
mm	O
stricture	O
that	O
appeared	O
at	O
28	O
cm	O
from	O
the	O
incisors	O
was	O
seen	O
in	O
the	O
lower	O
third	O
of	O
the	O
esophagus.	O
The	O
scope	O
did	O
not	O
traverse	O
the	O
lesion.	O
A	O
8mm	O
balloon	O
was	O
introduced	O
for	O
dilation	O
successfully.	O
Other	O
After	O
dilation	O
an	O
attempt	O
was	O
made	O
to	O
pass	O
the	O
baby	O
endoscope	O
beyond	O
the	O
stricture	O
and	O
the	O
area	O
was	O
too	O
narrow	O
to	O
allow	O
passage.	O
Stomach:	O
not	O
examined	O
Duodenum:	O
not	O
examined	O
Impression:	O
Stricture	O
of	O
the	O
lower	O
third	O
of	O
the	O
esophagus	O
(dilation)	O
After	O
dilation	O
an	O
attempt	O
was	O
made	O
to	O
pass	O
the	O
baby	O
endoscope	O
beyond	O
the	O
stricture	O
and	O
the	O
area	O
was	O
too	O
narrow	O
to	O
allow	O
passage.	O
Recommendations:	O
If	O
any	O
questions	O
or	O
you	O
need	O
to	O
schedule	O
an	O
office	O
appointment	O
or	O
procedure	O
call	O
___	O
MD	O
at	O
___	O
or	O
email	O
at	O
___.	O
To	O
properly	O
dilate	O
this	O
likely	O
radiation	O
stricture	O
sfely	O
flouroscopy	O
is	O
needed.	O
I	O
have	O
discussed	O
this	O
with	O
Dr.	O
___	O
will	O
dilate	O
under	O
fluoro	O
today.	O
Additional	O
notes:	O
FINAL	O
DIAGNOSES	O
are	O
listed	O
in	O
the	O
impression	O
section	O
above.	O
Estimated	O
blood	O
loss	O
=	O
zero.	O
No	O
specimens	O
were	O
taken	O
for	O
pathology	O
Brief	O
Hospital	O
Course:	O
___	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
TAH/BSO	O
in	O
___	O
and	O
chronic	O
diarrhea	O
related	O
to	O
radiation,	O
who	O
has	O
a	O
recent	O
history	O
of	O
breast	O
cancer	O
(___)	O
treated	O
with	O
left	O
mastectomy	O
and	O
radiation	O
who	O
presents	O
with	O
nausea,	O
dysphagia	O
and	O
poor	O
PO	O
intake.	O
She	O
was	O
seen	O
in	O
the	O
ED	O
with	O
possible	O
partial	O
SBO	O
prior	O
to	O
___.	O
She	O
returned	O
with	O
nausea	O
and	O
vomiting	O
associated	O
with	O
meds	O
and	O
dysphagia.	O
She	O
had	O
a	O
CT	O
with	O
enteritis	O
treated	O
with	O
Cipro	O
and	O
Flagyl	O
x	O
5	O
days.	O
She	O
was	O
found	O
to	O
have	O
a	O
benign	O
appearing	O
distal	O
esophageal	O
stricture.	O
ACUTE	O
ISSUES:	O
--------------	O
ESOPHAGEAL	O
STRICTURE:	O
She	O
underwent	O
EGD	O
which	O
showed	O
lower	O
esophageal	O
stricture	O
though	O
unable	O
to	O
dilate	O
on	O
___.	O
.	O
UGI	O
series	O
confirmed	O
esoph	O
stricture.	O
On	O
___,	O
EGD	O
reattempted	O
(benign	O
in	O
appearance)	O
and	O
it	O
was	O
dilated	O
to	O
8	O
mm.	O
Liquids	O
were	O
reattempted	O
but	O
she	O
was	O
unable	O
to	O
tolerate	O
liquids.	O
Given	O
concerns	O
re:	O
malnutrition,	O
a	O
PEG	O
tube	O
was	O
requested	O
to	O
be	O
placed	O
by	O
___	O
on	O
___.	O
Repeat	O
dilation	O
was	O
attempted	O
on	O
two	O
more	O
occasions	O
and	O
was	O
unsuccessful.	O
GI	O
team	O
plans	O
to	O
attempt	O
a	O
repeat	O
dilation	O
in	O
two	O
weeks.	O
She	O
is	O
to	O
remain	O
NPO	O
until	O
esophageal	O
stricture	O
is	O
successfully	O
dilated.	O
HYPERTENSION:	O
BP	O
meds	O
held	O
as	O
she	O
was	O
normotensive	O
without	O
any	O
blood	O
pressure	O
medication.	O
Chronic	O
Diarrhea:	O
Per	O
the	O
patient	O
she	O
has	O
had	O
an	O
exhaustive	O
workup	O
for	O
chronic	O
diarrhea	O
that	O
was	O
performed	O
by	O
her	O
Gastroenterologist	O
at	O
___	O
that	O
revealed	O
that	O
her	O
diarrhea	O
was	O
secondary	O
to	O
effects	O
of	O
radiation	O
that	O
she	O
had	O
___	O
years	O
ago	O
after	O
her	O
hysterectomy.	O
She	O
continued	O
to	O
have	O
diarrhea	O
while	O
in	O
the	O
hospital	O
on	O
tube	O
feeds,	O
and	O
she	O
had	O
some	O
response	O
to	O
immodium.	O
Pain	O
at	O
site	O
of	O
GJ	O
tube:	O
She	O
was	O
evaluated	O
by	O
___	O
and	O
and	O
films	O
that	O
showed	O
the	O
GJ	O
tube	O
was	O
positioned	O
properly.	O
She	O
continued	O
to	O
have	O
pain	O
along	O
the	O
insertion	O
site	O
several	O
days	O
after	O
placement	O
-	O
likely	O
structural	O
-	O
she	O
had	O
an	O
adult	O
tube	O
placed	O
when	O
she	O
is	O
only	O
60	O
lbs.	O
She	O
responds	O
to	O
heat	O
packs	O
and	O
tylenol	O
for	O
the	O
pain.	O
___	O
does	O
not	O
feel	O
that	O
the	O
tube	O
needs	O
to	O
be	O
repositioned.	O
MALNUTRITION/Weight	B-Malnutrition
loss	B-Weight_loss
Hypokalemia,	O
hypomagnesemia,	O
hypophosphatemia	O
all	O
noted	O
on	O
admission:	O
Likely	O
due	O
to	O
malnutrition	B-Malnutrition
and	O
diarrhea.	O
She	O
was	O
repleted	O
aggressively	O
during	O
her	O
admission	O
and	O
her	O
abnormalities	O
were	O
corrected.	O
Her	O
weight	O
on	O
discharge	O
was	O
65	O
pounds.	O
I	O
have	O
talked	O
to	O
her	O
and	O
her	O
niece	O
and	O
friend.	O
They	O
all	O
report	O
very	O
rapid	O
weight	B-Weight_loss
loss	B-Weight_loss
in	O
the	O
past	O
few	O
months;	O
they	O
believed	O
that	O
her	O
recent	O
move	O
was	O
very	O
difficult	O
for	O
her	O
and	O
her	O
diarrhea	O
worsened	O
during	O
the	O
stress.	O
Her	O
weight	B-Weight_loss
loss	B-Weight_loss
also	O
accelerated	O
after	O
she	O
developed	O
an	O
esophageal	O
stricture	O
and	O
was	O
unable	O
to	O
take	O
PO.	O
I	O
discussed	O
with	O
her	O
and	O
her	O
HCP	O
at	O
length	O
her	O
overall	O
frailty	O
and	O
low	O
weight.	O
Perhaps	O
she	O
will	O
be	O
able	O
to	O
gain	O
weight	O
with	O
tube	O
feeds,	O
but	O
her	O
diarrhea	O
may	O
continue	O
(diarrhea	O
is	O
common	O
with	O
tube	O
feeds,	O
and	O
she	O
clearly	O
has	O
some	O
underlying	O
malabsorption	O
secondary	O
to	O
her	O
prior	O
radiation	O
treatment)	O
but	O
it	O
may	O
not.	O
Should	O
her	O
weight	B-Weight_loss
continue	O
to	O
fall,	B-Weight_loss
I	O
urged	O
her	O
to	O
reconsider	O
her	O
goals	O
of	O
care	O
and	O
to	O
consider	O
comfort	O
measures	O
and	O
discontinuation	O
of	O
the	O
tube.	O
She	O
is	O
a	O
DNR/DNI,	O
and	O
she	O
would	O
like	O
to	O
return	O
in	O
a	O
few	O
weeks	O
for	O
reattempt	O
at	O
dilation	O
of	O
the	O
esophageal	O
sphincter.	O
She	O
is	O
aware	O
of	O
her	O
overall	O
poor	O
health,	O
low	O
weight.	O
CHRONIC	O
ISSUES:	O
--------------	O
BREAST	O
CANCER:	O
Held	O
anastrozole	O
during	O
hospitalization	O
-	O
if	O
she	O
wishes	O
to	O
continue	O
it	O
at	O
rehab,	O
it	O
would	O
have	O
to	O
be	O
crushed	O
and	O
then	O
put	O
in	O
G	O
tube.	O
We	O
cancelled	O
her	O
oncology	O
f/u	O
given	O
her	O
overall	O
poor	O
condition.	O
If	O
her	O
weight	O
improves	O
she	O
may	O
consider	O
rescheduling	O
f/u.	O
Code	O
status:	O
DNR/DNI	O
I	O
discussed	O
her	O
condition	O
in	O
full	O
with	O
her	O
health	O
care	O
proxy.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Atenolol	O
50	O
mg	O
PO	O
DAILY	O
2.	O
anastrozole	O
1	O
mg	O
oral	O
daily	O
3.	O
Omeprazole	O
40	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Lansoprazole	O
Oral	O
Disintegrating	O
Tab	O
30	O
mg	O
G	O
TUBE	O
DAILY	O
2.	O
Acetaminophen	O
(Liquid)	O
650	O
mg	O
NG	O
Q6H:PRN	O
pain/fever	O
3.	O
LOPERamide	O
1	O
mg	O
PO	O
DAILY:PRN	O
diarrhea	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Enteritis	O
Dysphagia	O
Esophageal	O
stricture	O
Malnutrition	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	O
requires	O
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
to	O
___	O
with	O
difficulty	O
swallowing	O
food	O
and	O
pills.	O
You	O
were	O
taken	O
for	O
an	O
endoscopy	O
which	O
found	O
a	O
stricture	O
of	O
your	O
esophagus	O
-	O
this	O
was	O
thought	O
to	O
be	O
benign	O
(not	O
cancer).	O
The	O
stricture	O
was	O
dilated	O
on	O
___	O
to	O
8	O
mm	O
and	O
but	O
we	O
were	O
unable	O
to	O
dilate	O
it	O
further.	O
You	O
had	O
a	O
GJ	O
tube	O
placed	O
for	O
feeding	O
given	O
your	O
weight	B-Weight_loss
loss	B-Weight_loss
and	O
diarrhea.	O
We	O
are	O
discharging	O
you	O
to	O
rehab	O
with	O
the	O
hope	O
that	O
you	O
are	O
able	O
to	O
gain	O
weight	O
and	O
strength	O
as	O
a	O
result	O
of	O
your	O
supplemental	O
feedings.	O
Our	O
gastroenterologists	O
will	O
contact	O
you	O
at	O
the	O
rehab	O
because	O
they	O
would	O
like	O
to	O
attempt	O
a	O
dilation	O
again.	O
When	O
you	O
first	O
were	O
admitted,	O
you	O
seemed	O
to	O
have	O
an	O
infection	O
in	O
your	O
small	O
bowel	O
which	O
was	O
treated	O
with	O
antibiotics	O
for	O
5	O
days.	O
Followup	O
Instructions:	O
___	O

